Viatris shares settled down -7.85% after reaching an intraday low of -8.02%, despite reporting Q2 adjusted EPS and sales that beat estimates and raising FY2026 guidance. The significant decline suggests the market may have reacted to other factors or that the positive news was already anticipated.